Search result for 'new drugs'

Senores Pharma Acquires 14 ANDAs from Dr Reddy's

March 4, 2025 16:32

Senores Pharmaceuticals will acquire 14 Abbreviated New Drug Applications (ANDAs) from Dr Reddy's Laboratories for an undisclosed amount. The acquisition will be funded through the IPO proceeds.

Indian Pharma to Deliver 100 New Drugs by 2047: Zydus Chairman

February 21, 2025 17:57

Zydus Lifesciences Chairman Pankaj R Patel believes India can deliver 100 new drugs by 2047, emphasizing the need for innovation and societal benefit. Read more.

India's Pharma Landscape: Innovation & R&D Focus Needed - Eco Survey

January 31, 2025 14:33

India's pharmaceutical sector needs to prioritize innovation, new drug development, and biopharmaceuticals, as R&D spending lags behind global leaders, according to the Economic Survey...

Granules India Gets USFDA Nod for ADHD Treatment

January 30, 2025 14:05

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ADHD and Binge Eating Disorder in adults and children.

Natco Pharma Gets US FDA Approval for Generic Everolimus Tablets

January 30, 2025 11:36

Natco Pharma has received US FDA approval for its generic version of Everolimus tablets for oral suspension, indicated for patients with tuberous sclerosis complex. The drug is a generic version of...

Alembic Gets USFDA Nod for Generic Antidepressant Tablets

January 15, 2025 15:53

Alembic Pharmaceuticals has received USFDA approval for its generic version of Brexpiprazole tablets, used to treat major depressive disorder. The approval covers strengths ranging from 0.25 mg to...

Lupin Gets USFDA Approval for Generic Cystic Fibrosis Treatment

January 9, 2025 17:38

Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis. The approval marks a significant step for Lupin in the US market.

Zydus Lifesciences Partners with CVS Caremark for Diabetes Drugs

January 7, 2025 14:01

Zydus Lifesciences has partnered with CVS Caremark to add its diabetes medications, Zituvio, Zituvimet, and Zituvimet XR, to the latter's template formulary. This partnership will improve access to...

Alembic Gets USFDA Nod for Generic Anti-Epileptic Drug

December 20, 2024 16:30

Alembic Pharmaceuticals receives USFDA approval for generic Divalproex Sodium delayed-release capsules, a treatment for epilepsy. The drug is therapeutically equivalent to Depakote Sprinkle capsules.

Granules India Gets USFDA Nod for Generic ADHD Drug

December 17, 2024 15:50

Granules India's subsidiary receives USFDA approval for generic Lisdexamfetamine Dimesylate chewable tablets, a medication used to treat ADHD and binge eating disorder.

Caplin Point Labs Gets USFDA Nod for Generic Eyedrop - Difluprednate

December 16, 2024 14:07

Caplin Point Labs receives USFDA approval for its generic version of Difluprednate eye drop, indicated for inflammation and pain after ocular surgery. The approval marks a significant milestone...

Marksans Pharma Gets USFDA Approval for Generic Allergic Rhinitis Treatment

November 22, 2024 17:30

Marksans Pharma receives USFDA approval for its generic version of Loratadine tablets, a treatment for allergic rhinitis. The approval marks a significant milestone for the company.

Alembic Pharma Gets USFDA Nod for Generic Hypertension Treatment

November 11, 2024 12:46

Alembic Pharmaceuticals receives USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules, indicated for hypertension treatment. The approval covers various strengths of the...

TCS Invests Rs 72 Crore in South American Innovation

October 30, 2024 18:52

TCS invests Rs 72 crore in South America, partnering with Insper for AI, IoT, and spatial computing innovation. The collaboration aims to accelerate new drug development, enhance crop yields, and...

Dr Reddy's Launches New Drug for Chronic Constipation - BixiBat

October 28, 2024 17:51

Dr Reddy's Laboratories has launched BixiBat, a first-in-class drug for chronic constipation in India. The drug, Elobixibat, works by increasing bile acid concentration in the colon, leading to...

Alembic Pharma Gets USFDA Nod for Generic Hypertension Treatment

October 21, 2024 13:33

Alembic Pharmaceuticals receives USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules used to treat hypertension, offering a cost-effective alternative to the brand-name...

Torrent Pharma Fined Rs 6.32 Lakh by NPPA for Price Violation

October 18, 2024 17:33

Torrent Pharmaceuticals received a demand notice of Rs 6.32 lakh from the NPPA for launching a new drug without prior price approval. The NPPA enforces drug pricing regulations in India.

Granules India Gets USFDA Nod for Generic Depression Drug

October 18, 2024 13:40

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion Hydrochloride extended-release tablets USP (SR), expanding its presence in the US...

Alkem Licenses Drug for Diabetic Neuropathy in India

October 10, 2024 15:24

Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for diabetic peripheral neuropathy in India. The drug has shown promising nerve...

Zydus Lifesciences Gets USFDA Approval for Prostate Cancer Drug

October 2, 2024 16:22

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for the US market. The product will be manufactured at the company's...

Zydus Gets USFDA Approval for Generic Prostate Cancer Drug

September 28, 2024 17:49

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide capsules (40 mg), a generic prostate cancer treatment drug. The drug will be produced at the company's Moraiya, Ahmedabad...

Alembic Pharma Gets USFDA Nod for Generic Schizophrenia Drug

September 27, 2024 15:48

Alembic Pharmaceuticals receives USFDA approval for its generic version of Paliperidone extended-release tablets, indicated for treating schizophrenia. The drug is therapeutically equivalent to...

Eugia Steriles' Injectable Facility Gets FDA Approval

September 11, 2024 14:23

Eugia Steriles's new injectables facility in Andhra Pradesh has received its first product approval from the US FDA, marking a significant milestone for the company.

Alembic Pharma Gets USFDA Nod for Generic Albendazole Tablets

September 5, 2024 17:27

Alembic Pharmaceuticals has received USFDA approval for its generic version of Albendazole Tablets, indicated for treating infections caused by worms like Taenia solium and Echinococcus granulosus.

Zydus Lifesciences Gets USFDA Nod for Scopolamine Transdermal System

August 30, 2024 16:13

Zydus Lifesciences receives USFDA approval to market Scopolamine transdermal system for nausea and vomiting prevention. This is the fifth ANDA approval for Zydus in the transdermal portfolio.

Natco Pharma Files Generic Cancer Drug Application with USFDA - Business News

August 29, 2024 17:10

Natco Pharma has submitted an ANDA to the USFDA for a generic version of Novartis' Tabrecta, a cancer drug. The company expects to be eligible for 180 days of marketing exclusivity.

Alembic Pharma Gets USFDA Nod for Scalp Psoriasis Drug

August 26, 2024 17:07

Alembic Pharmaceuticals has received USFDA approval to market a generic medication for treating moderate-to-severe scalp psoriasis. The drug, Betamethasone Valerate Foam, is therapeutically...

Granules India Gets USFDA Nod for Generic Glycopyrrolate Oral Solution

August 20, 2024 14:45

Granules India receives USFDA approval for its generic Glycopyrrolate oral solution, indicated for pediatric patients with drooling due to neurological conditions.

Alembic Gets USFDA Approval for Generic Deep Vein Thrombosis Medication

August 13, 2024 16:54

Alembic Pharmaceuticals receives USFDA approval for its generic Dabigatran Etexilate Capsules (110 mg) for deep vein thrombosis and pulmonary embolism prophylaxis.

Alembic Pharma Gets USFDA Approval for Generic Cancer Drug

August 2, 2024 13:18

Alembic Pharmaceuticals receives USFDA approval to market generic Nelarabine Injection for cancer treatment, expanding its portfolio to 211 ANDA approvals.

Rubicon Research Files Rs 1,085 Cr IPO: Pharma Formulation Firm Aims to Raise Funds

August 1, 2024 12:16

Pharmaceutical formulation company Rubicon Research has filed draft papers with Sebi for a Rs 1,085 crore IPO. The IPO includes a fresh issue of shares and an Offer For Sale by promoter General...

Senores Pharma IPO: Rs 500 Cr Raise, US Expansion

July 29, 2024 13:33

Senores Pharmaceuticals files IPO papers with Sebi to raise Rs 500 crore, aiming to expand its US operations and set up a new manufacturing facility.

Pharma Sector Growth: Skills, Innovation Key - Economic Survey

July 22, 2024 13:39

India's pharma sector, valued at USD 50 billion, is projected to reach USD 130 billion by 2030. Economic Survey highlights the need for skill development, innovation, and a robust supply chain for...

Zydus Lifesciences Gets USFDA Nod for Diabetes Drug - Zituvimet XR

July 19, 2024 12:16

Zydus Lifesciences receives USFDA approval for its new drug application for Zituvimet XR (sitagliptin and metformin hydrochloride) extended-release tablets, a diabetes medication. This marks the...

Glenmark Gets USFDA Approval for Generic Seizure Drug

July 18, 2024 14:21

Glenmark Pharmaceuticals receives USFDA approval to market generic Topiramate Capsules, a medication used for treating and preventing seizures. The drug will be distributed in the US by Glenmark...

Glenmark Pharma Gets USFDA Approval for Seizure Drug

July 17, 2024 09:47

Glenmark Pharmaceuticals has received USFDA approval for its generic Topiramate capsules used to treat seizures. The drug is bioequivalent to Topamax capsules.

Alembic Gets USFDA Nod for Generic Selexipag Injection

July 15, 2024 13:32

Alembic Pharmaceuticals receives tentative USFDA approval for its generic Selexipag injection, a treatment for pulmonary arterial hypertension. The company may be eligible for 180 days of generic...

Alembic Pharma Gets USFDA Nod for Generic Bromfenac Ophthalmic Solution

July 9, 2024 14:13

Alembic Pharmaceuticals receives USFDA approval for its generic Bromfenac ophthalmic solution, indicated for post-cataract surgery inflammation and pain treatment.

Alembic Pharma Gets USFDA Approval for Ivosidenib Tablets

July 4, 2024 15:00

Alembic Pharmaceuticals receives tentative USFDA approval for its generic Ivosidenib tablets, a treatment for certain types of cancer of bone marrow and bile duct. The drug is therapeutically...

Orchid Pharma & Cipla Partner for New Antibiotic in India

June 28, 2024 19:42

Orchid Pharma and Cipla collaborate to distribute Cefepime-Enmetazobactam, a new antibiotic for complicated infections, across India. The partnership aims to combat antimicrobial resistance and...

Alembic Pharma gets USFDA nod for Dabigatran Etexilate capsules

June 18, 2024 16:02

Alembic Pharmaceuticals receives USFDA approval for generic Dabigatran Etexilate capsules 75 mg & 150 mg, used for stroke and blood clot prevention in adults with atrial fibrillation. The company...

Alembic Pharma Gets USFDA Approval for Hereditary Angioedema Injection

June 17, 2024 13:29

Alembic Pharmaceuticals receives USFDA approval for its generic Icatibant injection, a treatment for acute attacks of hereditary angioedema (HAE) in adults. This is the company's first peptide...

Lupin Launches Generic Drugs in US: USFDA Approval

June 3, 2024 17:11

Lupin has received USFDA approval to launch generic Doxycycline for Injection and Letermovir Tablets in the US market, targeting a combined annual market value of USD 362 million.

Zydus Lifesciences & MSN Partner for Generic Cancer Drug in US

May 17, 2024 11:21

Zydus Lifesciences has partnered with MSN Laboratories to bring a generic version of the cancer drug Cabozantinib to the US market, aiming to provide affordable treatment options.

Glenmark Pharma Gets USFDA Nod for Generic Anti-Inflammatory Drug

April 29, 2024 10:39

Glenmark Pharmaceuticals receives USFDA approval to sell generic Acetaminophen and Ibuprofen tablets, a version of Advil 2 Dual Action. The company's product is expected to achieve significant...

Lupin Gets USFDA Nod for Generic Tardive Dyskinesia Drug

April 8, 2024 16:01

Lupin has received USFDA approval to market a generic medication for tardive dyskinesia, a movement disorder. The drug, Valbenazine Capsules, is a generic equivalent of Ingrezza Capsules and is...

Sanofi Plans Accelerated Growth in India with New Drugs && Partnerships

April 7, 2024 11:15

French drugmaker Sanofi aims for a larger share of the Indian market, introducing new drugs, localizing production, and partnering with domestic firms to expand its reach.

Orchid Pharma Gets USFDA Approval for UTI Drug

February 23, 2024 16:22

Orchid Pharma has received USFDA approval for Enmetazobactam, a new drug to treat complicated urinary tract infections. This marks a significant development in addressing global antimicrobial...

Lupin Gets USFDA Approval for Pregnancy Prevention Drug

February 16, 2024 14:02

Lupin Ltd. receives USFDA approval to market its generic 'Minzoya' tablets for pregnancy prevention. The drug is a generic equivalent of Balcoltra, with estimated annual sales of USD 42 million in...

Orchid Pharma's New Antibiotic 'Exblifeb' Approved by EMA

January 30, 2024 12:52

Orchid Pharma's 'Exblifeb', featuring Enmetazobactam, a novel beta-lactamase inhibitor, receives EMA approval for treating UTIs, pneumonia, and bacteremia.

Pharma Industry to Reach USD 200 Billion by 2030: Biocon Chief

January 24, 2024 19:46

Biocon's Kiran Mazumdar-Shaw says research-based incentives for innovative drugs can boost India's pharma industry to USD 200 billion by 2030, highlighting the need for drug innovation and digital...

Lupin Gets USFDA Approval for Generic Hyperuricemia Drug

January 18, 2024 17:37

Lupin receives USFDA approval to market generic Febuxostat tablets for the treatment of hyperuricemia in adults with gout. The drug, a generic equivalent of Uloric, will be manufactured in India.

Aragen Life Sciences Invests Rs 2,000 Cr in Hyderabad Expansion

January 17, 2024 15:21

Aragen Life Sciences announces Rs 2,000 crore investment in Hyderabad to expand its facility, creating 1,500 new jobs and solidifying the city's position as a hub for CROs.

Lupin Gets USFDA Approval for Generic Diabetes Drug

January 4, 2024 19:17

Lupin receives USFDA approval to market a generic version of AstraZeneca's Qtern tablets, a medication for type 2 diabetes. The drug will be manufactured at Lupin's Pithampur facility.

Lupin Gets USFDA Approval for Generic Diabetes Drug

January 4, 2024 19:12

Lupin has received USFDA approval to market a generic medication for type 2 diabetes, a generic equivalent of AstraZeneca's Qtern tablets. The drug will be manufactured at Lupin's Pithampur facility.

BDR Pharma Launches Oral Prostate Cancer Drug BDENZA

January 2, 2024 13:30

BDR Pharmaceuticals introduces Enzalutamide oral solution, BDENZA, for prostate cancer treatment. The company claims it's the first in the world to offer this drug delivery system, providing a more...

Lupin Gets USFDA Approval for Generic Loteprednol Etabonate

December 27, 2023 16:35

Lupin has received USFDA approval for its generic Loteprednol Etabonate ophthalmic suspension, a treatment for seasonal allergic conjunctivitis. The product is a generic equivalent to Alrex...

Natco Pharma Anti-trust Lawsuit Dismissed in US

December 21, 2023 18:24

Natco Pharma has had anti-trust claims against it regarding a generic cancer treatment drug in the US dismissed. The lawsuit was filed by Louisiana Health Service & Indemnity Company.

Granules India Gets USFDA Approval for Generic Pantoprazole

December 13, 2023 13:06

Granules India receives USFDA approval for generic pantoprazole sodium delayed-release tablets for treating erosive esophagitis associated with GERD.

Dr Reddy's & Coya Partner for ALS Treatment Drug

December 6, 2023 20:23

Dr Reddy's Laboratories and Coya Therapeutics have inked a licensing agreement to develop a combination therapy for amyotrophic lateral sclerosis (ALS). The deal includes an upfront payment and...

Lupin Gets USFDA Approval for Generic Smoking Cessation Tablets

December 6, 2023 10:55

Lupin receives USFDA approval for its generic Varenicline tablets, a smoking cessation treatment. This approval marks a significant step for the company, with the product expected to be...

Zydus Lifesciences Gets USFDA Nod for Generic Heart Failure Drug

December 1, 2023 14:50

Zydus Lifesciences receives USFDA approval for its generic version of Ivabradine tablets, indicated for the treatment of heart failure. The drug will be manufactured in Ahmedabad, India.

Aurobindo Pharma Gets USFDA Approval for HIV Drug

November 29, 2023 12:54

Aurobindo Pharma receives USFDA approval to market a generic HIV-1 treatment drug, Darunavir tablets, in strengths of 600 mg and 800 mg. The drug is therapeutically equivalent to Prezista tablets.

Company Name
Price
Volume

Vodafone Idea L
6.81 ( -1.73)
117225274

Srestha Finvest
0.48 ( -4.00)
23917778

G G Engineering
0.81 ( -2.41)
23181029

Shangar Decor
1.11 (+ 4.72)
20087292

Guj. Toolroom Lt
1.40 ( -4.76)
17858668

MORE NEWS

NITI NCAER States Economic Forum Portal Launched

Indian-American Executive Leads Wharton AI & Analytics Initiative

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2025	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

Search result for 'new drugs'

Senores Pharma Acquires 14 ANDAs from Dr Reddy's

Indian Pharma to Deliver 100 New Drugs by 2047: Zydus Chairman

India's Pharma Landscape: Innovation &amp; R&amp;D Focus Needed - Eco Survey

Granules India Gets USFDA Nod for ADHD Treatment

Natco Pharma Gets US FDA Approval for Generic Everolimus Tablets

Alembic Gets USFDA Nod for Generic Antidepressant Tablets

Lupin Gets USFDA Approval for Generic Cystic Fibrosis Treatment

Zydus Lifesciences Partners with CVS Caremark for Diabetes Drugs

Alembic Gets USFDA Nod for Generic Anti-Epileptic Drug

Granules India Gets USFDA Nod for Generic ADHD Drug

Caplin Point Labs Gets USFDA Nod for Generic Eyedrop - Difluprednate

Marksans Pharma Gets USFDA Approval for Generic Allergic Rhinitis Treatment

Alembic Pharma Gets USFDA Nod for Generic Hypertension Treatment

TCS Invests Rs 72 Crore in South American Innovation

Dr Reddy's Launches New Drug for Chronic Constipation - BixiBat

Alembic Pharma Gets USFDA Nod for Generic Hypertension Treatment

Torrent Pharma Fined Rs 6.32 Lakh by NPPA for Price Violation

Granules India Gets USFDA Nod for Generic Depression Drug

Alkem Licenses Drug for Diabetic Neuropathy in India

Zydus Lifesciences Gets USFDA Approval for Prostate Cancer Drug

Zydus Gets USFDA Approval for Generic Prostate Cancer Drug

Alembic Pharma Gets USFDA Nod for Generic Schizophrenia Drug

Eugia Steriles' Injectable Facility Gets FDA Approval

Alembic Pharma Gets USFDA Nod for Generic Albendazole Tablets

Zydus Lifesciences Gets USFDA Nod for Scopolamine Transdermal System

Natco Pharma Files Generic Cancer Drug Application with USFDA - Business News

Alembic Pharma Gets USFDA Nod for Scalp Psoriasis Drug

Granules India Gets USFDA Nod for Generic Glycopyrrolate Oral Solution

Alembic Gets USFDA Approval for Generic Deep Vein Thrombosis Medication

Alembic Pharma Gets USFDA Approval for Generic Cancer Drug

Rubicon Research Files Rs 1,085 Cr IPO: Pharma Formulation Firm Aims to Raise Funds

Senores Pharma IPO: Rs 500 Cr Raise, US Expansion

Pharma Sector Growth: Skills, Innovation Key - Economic Survey

Zydus Lifesciences Gets USFDA Nod for Diabetes Drug - Zituvimet XR

Glenmark Gets USFDA Approval for Generic Seizure Drug

Glenmark Pharma Gets USFDA Approval for Seizure Drug

Alembic Gets USFDA Nod for Generic Selexipag Injection

Alembic Pharma Gets USFDA Nod for Generic Bromfenac Ophthalmic Solution

Alembic Pharma Gets USFDA Approval for Ivosidenib Tablets

Orchid Pharma & Cipla Partner for New Antibiotic in India

Alembic Pharma gets USFDA nod for Dabigatran Etexilate capsules

Alembic Pharma Gets USFDA Approval for Hereditary Angioedema Injection

Lupin Launches Generic Drugs in US: USFDA Approval

Zydus Lifesciences & MSN Partner for Generic Cancer Drug in US

Glenmark Pharma Gets USFDA Nod for Generic Anti-Inflammatory Drug

Lupin Gets USFDA Nod for Generic Tardive Dyskinesia Drug

Sanofi Plans Accelerated Growth in India with New Drugs && Partnerships

Orchid Pharma Gets USFDA Approval for UTI Drug

Lupin Gets USFDA Approval for Pregnancy Prevention Drug

Orchid Pharma's New Antibiotic 'Exblifeb' Approved by EMA

Pharma Industry to Reach USD 200 Billion by 2030: Biocon Chief

Lupin Gets USFDA Approval for Generic Hyperuricemia Drug

Aragen Life Sciences Invests Rs 2,000 Cr in Hyderabad Expansion

Lupin Gets USFDA Approval for Generic Diabetes Drug

Lupin Gets USFDA Approval for Generic Diabetes Drug

BDR Pharma Launches Oral Prostate Cancer Drug BDENZA

Lupin Gets USFDA Approval for Generic Loteprednol Etabonate

Natco Pharma Anti-trust Lawsuit Dismissed in US

Granules India Gets USFDA Approval for Generic Pantoprazole

Dr Reddy's & Coya Partner for ALS Treatment Drug

Lupin Gets USFDA Approval for Generic Smoking Cessation Tablets

Zydus Lifesciences Gets USFDA Nod for Generic Heart Failure Drug

Aurobindo Pharma Gets USFDA Approval for HIV Drug

TODAY'S MOST TRADED COMPANIES

MORE NEWS

Moneywiz Live!

ALL MONEYWIZ PAGES

India's Pharma Landscape: Innovation & R&D Focus Needed - Eco Survey